Inflammatory disease Archives

Podcast 10 Jan 2025

Fighting pain with non-opioid drugs

In the first episode of 2025, we talk about non-opioid pain drugs with Brixton Biosciences.

January 10, 2025

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration.

November 26, 2024 - 9 minutesmins - By Jules Adam

Podcast 1 Nov 2024

The immunometabolism landscape

To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty.

November 1, 2024

In Depth 16 Oct 2024

JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer?

Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer.

October 16, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 3 Oct 2024

Resolution Therapeutics raises $85 million to advance its macrophage therapy

Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.

October 3, 2024 - 7 minutesmins - By Jules Adam

Podcast 13 Sep 2024

Targeting inflammation: A revolution in disease treatment

NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies. Listen to our conversation with Halia Therapeutics about it.

September 13, 2024

In Depth 30 Jul 2024

Why is the immunology and inflammation market suddenly attracting a wave of investment?

Discover why the immunology and inflammation market has recently been attracting a major wave of investment.

July 30, 2024 - 13 minutesmins - By Willow Shah-Neville

In Depth 25 Jul 2024

The future of inflammatory bowel disease treatment: what is on the horizon?

Ongoing clinical trials aim to address inflammatory bowel disease, which is caused by an overactive immune system that causes symptoms affecting the gut.

July 25, 2024 - 8 minutesmins - By Roohi Mariam Peter

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […]

October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 15 Aug 2023

Can stem cell treatment repair damaged knees?

Scientists’ fascination with amphibians like axolotls and newts, animals that are capable of scarlessly regrowing their limbs, sparked the idea of possibly replicating this in humans. Since 1958, when French oncologist Georges Mathe performed the first-ever stem cell transplantation – to save six nuclear researchers who were accidentally exposed to radiation – the technology has […]

August 15, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 31 Jul 2023

Biogen acquiring Reata Pharmaceuticals for $7.3B

Biogen Inc. and Reata Pharmaceuticals, Inc. have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. Reata has made advancements developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases. Reata’s FDA-approved SKYCLARYS (omaveloxolone) is […]

July 31, 2023 - 3 minutesmins - By Jim Cornall

Podcast 20 Jul 2023

Beyond Biotech podcast 55: Inflammasomes

This week on our podcast, we’re talking about inflammasome inhibitors with Alan Watt, CEO of NodThera. The company recently announced it is the first to show a reduction in neuroinflammation with an inflammasome inhibitor. NodThera announced positive initial data from four subjects in the elderly volunteer stage of its phase Ib/IIa study evaluating the effects […]

July 20, 2023

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Inflammatory disease

Fighting pain with non-opioid drugs

Seven miRNA-focused companies pioneering new therapies in 2024

The immunometabolism landscape

JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer?

Resolution Therapeutics raises $85 million to advance its macrophage therapy

Targeting inflammation: A revolution in disease treatment

Why is the immunology and inflammation market suddenly attracting a wave of investment?

The future of inflammatory bowel disease treatment: what is on the horizon?

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Can stem cell treatment repair damaged knees?

Biogen acquiring Reata Pharmaceuticals for $7.3B

Beyond Biotech podcast 55: Inflammasomes

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!